CKX Lands, Inc. (CKX) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 693.40K USD | |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 3.32M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $693.40K | (m) | $3.32M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $661.02K | (m) | $3.45M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $838.54K | $0.00 | $3.64M | (m) | (m) | 0.00% | (m) | (m) |
| 2025-09-30 | (m) | $897.33K | $0.00 | $309.57K | (m) | (m) | 0.00% | (m) | (m) |
| 2025-06-30 | (m) | $835.96K | $12.62K | $179.29K | (m) | (m) | 1.51% | (m) | (m) |
| 2025-03-31 | (m) | $1.73M | $118.12K | $665.75K | (m) | (m) | 6.84% | (m) | (m) |
| 2024-12-31 | (m) | $1.52M | $223.63K | $116.99K | (m) | (m) | 14.70% | (m) | (m) |
| 2024-09-30 | (m) | $2.03M | $329.13K | $551.31K | (m) | (m) | 16.21% | (m) | (m) |
| 2024-06-30 | (m) | $2.12M | $422.02K | $572.05K | (m) | (m) | 19.92% | (m) | (m) |
| 2024-03-31 | (m) | (m) | $420.87K | $28.03K | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $1.49M | $841.84K | $121.82K | (m) | (m) | 56.67% | (m) | (m) |
| 2023-09-30 | (m) | $1.08M | $2.34M | $-1.67M | (m) | (m) | 216.74% | (m) | (m) |
| 2023-06-30 | (m) | $1.15M | $2.53M | $-1.78M | (m) | (m) | 219.67% | (m) | (m) |
| 2023-03-31 | (m) | $1.09M | $2.84M | $-2.18M | (m) | (m) | 260.25% | (m) | (m) |
| 2022-12-31 | (m) | $1.11M | $2.31M | $-1.84M | (m) | (m) | 208.82% | (m) | (m) |
| 2022-09-30 | (m) | $1.03M | (m) | $-300.28K | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $870.49K | (m) | $74.78K | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $771.59K | (m) | $612.95K | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $744.54K | (m) | $1.06M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $681.74K | (m) | $1.00M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $669.04K | (m) | $800.16K | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $646.43K | (m) | $771.42K | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $671.94K | (m) | $379.05K | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $742.58K | (m) | $382.69K | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $810.08K | (m) | $363.92K | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $838.19K | (m) | $158.20K | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $811.27K | (m) | $191.61K | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $794.96K | (m) | $158.95K | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $824.32K | (m) | $180.30K | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $1.00M | (m) | $409.73K | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.19M | (m) | $1.37M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $1.35M | (m) | $1.53M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $1.29M | (m) | $1.53M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $1.29M | (m) | $1.56M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $1.14M | (m) | $541.13K | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $1.02M | (m) | $420.88K | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $1.03M | (m) | $357.17K | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $773.87K | (m) | $80.73K | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $863.40K | (m) | $187.36K | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $818.63K | (m) | $173.98K | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $961.82K | (m) | $356.17K | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $1.10M | (m) | $669.93K | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $1.06M | (m) | $650.70K | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $1.37M | (m) | $757.91K | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $2.06M | (m) | $1.39M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $2.25M | (m) | $1.55M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $2.62M | (m) | $1.91M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $2.67M | (m) | $1.89M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $2.21M | (m) | $1.47M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $2.20M | (m) | $1.50M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $2.11M | (m) | $1.37M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | $2.37M | (m) | $1.68M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $2.51M | (m) | $1.78M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $2.86M | (m) | $2.10M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $3.26M | (m) | $2.51M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | $3.12M | (m) | $2.37M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $3.06M | (m) | $2.34M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $2.61M | (m) | $1.91M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $1.98M | (m) | $1.31M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $1.67M | (m) | $1.06M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEXCO ENERGY CORP (MXC) | United States | $0.022B | 10.07 |
| EON Resources Inc. (EONR) | United States | $0.026B | |
| BARNWELL INDUSTRIES INC (BRN) | United States | $0.014B | -2.71 |
| AleAnna, Inc. (ANNA) | United States | $0.013B | |
| Trio Petroleum Corp (TPET) | United States | $0.009B | |
| New Concept Energy, Inc. (GBR) | United States | $0.004B | |
| Arcadia Biosciences, Inc. (RKDA) | United States | $0.001B | |
| Prairie Operating Co. (PROP) | United States | $0.047B | -1.72 |
| ABUNDIA GLOBAL IMPACT GROUP, INC. (AGIG) | United States | $0.057B | -1.20 |
| BATTALION OIL CORP (BATL) | United States | $0.064B |